297 related articles for article (PubMed ID: 20956506)
1. Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy.
Kang X; Zhang Q; Wang S; Huang X; Jin S
CMAJ; 2010 Nov; 182(17):1857-62. PubMed ID: 20956506
[TBL] [Abstract][Full Text] [Related]
2. Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study.
Guha N; Kwan ML; Quesenberry CP; Weltzien EK; Castillo AL; Caan BJ
Breast Cancer Res Treat; 2009 Nov; 118(2):395-405. PubMed ID: 19221874
[TBL] [Abstract][Full Text] [Related]
3. Soy food intake and breast cancer survival.
Shu XO; Zheng Y; Cai H; Gu K; Chen Z; Zheng W; Lu W
JAMA; 2009 Dec; 302(22):2437-43. PubMed ID: 19996398
[TBL] [Abstract][Full Text] [Related]
4. Pre-diagnosis and early post-diagnosis dietary soy isoflavone intake and survival outcomes: A prospective cohort study of early stage breast cancer survivors.
Ho SC; Yeo W; Goggins W; Kwok C; Cheng A; Chong M; Lee R; Cheung KL
Cancer Treat Res Commun; 2021; 27():100350. PubMed ID: 33770661
[TBL] [Abstract][Full Text] [Related]
5. Dietary isoflavone intake and all-cause mortality in breast cancer survivors: The Breast Cancer Family Registry.
Zhang FF; Haslam DE; Terry MB; Knight JA; Andrulis IL; Daly MB; Buys SS; John EM
Cancer; 2017 Jun; 123(11):2070-2079. PubMed ID: 28263368
[TBL] [Abstract][Full Text] [Related]
6. Soy product and isoflavone intake and breast cancer risk defined by hormone receptor status.
Zhang C; Ho SC; Lin F; Cheng S; Fu J; Chen Y
Cancer Sci; 2010 Feb; 101(2):501-7. PubMed ID: 19860847
[TBL] [Abstract][Full Text] [Related]
7. Adolescent and adult soy food intake and breast cancer risk: results from the Shanghai Women's Health Study.
Lee SA; Shu XO; Li H; Yang G; Cai H; Wen W; Ji BT; Gao J; Gao YT; Zheng W
Am J Clin Nutr; 2009 Jun; 89(6):1920-6. PubMed ID: 19403632
[TBL] [Abstract][Full Text] [Related]
8. Soy intake in association with menopausal symptoms during the first 6 and 36 months after breast cancer diagnosis.
Dorjgochoo T; Gu K; Zheng Y; Kallianpur A; Chen Z; Zheng W; Lu W; Shu XO
Breast Cancer Res Treat; 2011 Dec; 130(3):879-89. PubMed ID: 20703939
[TBL] [Abstract][Full Text] [Related]
9. Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status.
Touillaud MS; Thiébaut AC; Fournier A; Niravong M; Boutron-Ruault MC; Clavel-Chapelon F
J Natl Cancer Inst; 2007 Mar; 99(6):475-86. PubMed ID: 17374837
[TBL] [Abstract][Full Text] [Related]
10. Soy and isoflavones consumption and breast cancer survival and recurrence: a systematic review and meta-analysis.
Qiu S; Jiang C
Eur J Nutr; 2019 Dec; 58(8):3079-3090. PubMed ID: 30382332
[TBL] [Abstract][Full Text] [Related]
11. The association of soy food consumption with the risk of subtype of breast cancers defined by hormone receptor and HER2 status.
Baglia ML; Zheng W; Li H; Yang G; Gao J; Gao YT; Shu XO
Int J Cancer; 2016 Aug; 139(4):742-8. PubMed ID: 27038352
[TBL] [Abstract][Full Text] [Related]
12. Soy products in the management of breast cancer.
Magee PJ; Rowland I
Curr Opin Clin Nutr Metab Care; 2012 Nov; 15(6):586-91. PubMed ID: 23075937
[TBL] [Abstract][Full Text] [Related]
13. Differential influence of dietary soy intake on the risk of breast cancer recurrence related to HER2 status.
Woo HD; Park KS; Ro J; Kim J
Nutr Cancer; 2012; 64(2):198-205. PubMed ID: 22211813
[TBL] [Abstract][Full Text] [Related]
14. Soy food and isoflavone intake and endometrial cancer risk: the Japan Public Health Center-based prospective study.
Budhathoki S; Iwasaki M; Sawada N; Yamaji T; Shimazu T; Sasazuki S; Inoue M; Tsugane S;
BJOG; 2015 Feb; 122(3):304-11. PubMed ID: 24941880
[TBL] [Abstract][Full Text] [Related]
15. Positive effects of soy isoflavone food on survival of breast cancer patients in China.
Zhang YF; Kang HB; Li BL; Zhang RM
Asian Pac J Cancer Prev; 2012; 13(2):479-82. PubMed ID: 22524810
[TBL] [Abstract][Full Text] [Related]
16. Dietary isoflavone intake is not statistically significantly associated with breast cancer risk in the Multiethnic Cohort.
Morimoto Y; Maskarinec G; Park SY; Ettienne R; Matsuno RK; Long C; Steffen AD; Henderson BE; Kolonel LN; Le Marchand L; Wilkens LR
Br J Nutr; 2014 Sep; 112(6):976-83. PubMed ID: 25201305
[TBL] [Abstract][Full Text] [Related]
17. Study on soy isoflavone consumption and risk of breast cancer and survival.
Kang HB; Zhang YF; Yang JD; Lu KL
Asian Pac J Cancer Prev; 2012; 13(3):995-8. PubMed ID: 22631686
[TBL] [Abstract][Full Text] [Related]
18. Dietary soy and isoflavone intake and risk of colorectal cancer in the Japan public health center-based prospective study.
Akhter M; Inoue M; Kurahashi N; Iwasaki M; Sasazuki S; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2128-35. PubMed ID: 18708407
[TBL] [Abstract][Full Text] [Related]
19. Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary.
Messina MJ; Wood CE
Nutr J; 2008 Jun; 7():17. PubMed ID: 18522734
[TBL] [Abstract][Full Text] [Related]
20. Intake of phytoestrogen foods and supplements among women recently diagnosed with breast cancer in Ontario, Canada.
Boucher BA; Cotterchio M; Curca IA; Kreiger N; Harris SA; Kirsh VA; Goodwin PJ
Nutr Cancer; 2012; 64(5):695-703. PubMed ID: 22642930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
